EPA Halts Dacthal Pesticide Use Amid Health Risk Concerns

EPA's Emergency Suspension of Dacthal

The U.S. Environmental Protection Agency (EPA) has recently issued an emergency order under the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA) to halt the usage of the pesticide dimethyl tetrachloroterephthalate (DCPA or Dacthal). This unprecedented move comes amid accumulating evidence that highlights severe health risks posed by Dacthal, particularly to vulnerable populations such as pregnant women and farmworkers.

This historic action is notably the first of its kind in almost four decades. The severity underscored by this emergency suspension reveals the potential danger Dacthal poses, especially considering its pervasive use in agriculture which results in widespread exposure.

Health Risks and Regulatory Actions

Exposure to Dacthal can lead to various adverse health outcomes, especially in pregnant women. Research indicates that contact with this pesticide can cause changes in fetal thyroid hormone levels. The repercussions of such hormonal disruptions include low birth weight, impaired brain development, lowered IQ, and impaired motor skills in unborn babies. These findings suggest that even when precautions like personal protective equipment are used, the risks remain significant.

The EPA, under the Biden-Harris Administration, has been advocating for the submission of essential data to better assess Dacthal's risks. In 2013, the agency issued a Data Call-In (DCI) to AMVAC Chemical Corporation, the sole manufacturer of Dacthal, demanding over 20 studies to support the continued registration of the pesticide. However, many submitted studies were deemed scientifically insufficient, especially those meant to evaluate thyroid impacts.

Support from Advocacy Groups and Future Actions

Community and advocacy groups have overwhelmingly supported the EPA's decision. Organizations like Alianza Nacional de Campesinas, which focuses on farmworker health and safety, particularly for pregnant women, have applauded the EPA’s steps. The agency’s proactive stance is set to culminate with an announcement of intent to cancel Dacthal products within the next 90 days, underlining the EPA's commitment to public health and safety regulations.

Key takeaways from this ongoing regulatory action include:

• Recognition of the heightened health risks posed by Dacthal, particularly to pregnant women and farm workers.
• Highlighting the significance of adequate scientific studies to substantiate pesticide safety.
• Efforts from the EPA to protect public health through stringent regulatory actions.

Here's a thought to consider

The EPA's decisive action serves as a reminder of the importance of rigorous scientific evaluation and the prioritization of public health in regulatory practices. Ensuring the safety of both the population and the environment hinges on continuous vigilance and responsiveness to emerging data.

Looking for updates? Sign up to our newsletter for weekly snippets.